Option chain shows key data for Virpax Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Virpax Pharmaceuticals.

Virpax Pharmaceuticals (OTC:VRPX) Stock, Option Chain

Virpax Pharmaceuticals

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Five,Below,Now,Open,-,Closeup,Of,Sign,On,Building

AGMH

AKBA

BHIL

DEVS

EFXT

FIVE

IOBT

MAZE

MHUA

OPTN

RVSB

VRPX

ZCAR

Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Wall Street Braces for More Uncertainty

Equities

Market Summary

News

Futures

Economics

Federal Reserve

Pre-Market Outlook

Markets

MCHP

NVDA

U.S. stock futures rose on Thursday following the Federal Open Market Committee&#39;s decision on Wednesday calling inflation &#39;transitory&#39;.

US Stocks Likely To Open Lower After Fed Decision: Any Pullback In Equities &#39;Offers An Opportunity,&#39; Says Expert

green chart shutter

Movers

Trading Ideas

ABSI

ATER

BOWN

CNSP

CRGX

FEAM

INTZ

KBSX

OSRH

STBX

STNE

TNXP

XHLD

Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket

VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals Inc

Press Releases

Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals' $6 Million Follow-On Offering

Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference

Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study

Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology

Stocks Under $1: PMAX PRSO ARBB KAVL to Watch in March 2025 – More Stocks Inside

Virpax's NES100 to be Presented at The Society of Toxicology by NCATS

Virpax Looking to Use MET to Develop Intranasal COVID Vaccine

Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND

Comments

Virpax Pharmaceuticals

Virpax Pharmaceuticals (VRPX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga